Author

Charles L. Dulberger

BioNTech (United States)ORCID 0000-0002-1334-5468Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

Gavin M. PalowitchiD· 2 shared Hannah A. Miller· 2 shared Adam ZuianiiD· 1 shared Adriana BadarauiD· 1 shared Alex S. HaniD· 1 shared Alexandra C. WallsiD· 1 shared Alibek GaleeviD· 1 shared Andrea Majoros-Hashempour· 1 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Gavin M. PalowitchORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 24, 2026

Comprehensive Profiling of Monkeypox Virus Antigens Identifies Potent Targets for Next-Generation mRNA Vaccine Development

Alexandra C. Walls, Harman Malhi, Gavin M. Palowitch…·Adam Zuiani

This study identifies potent MPXV antigens for mRNA vaccine development by testing neutralizing antibodies against various surface proteins in mice.

DOI 10.64898/2026.06.23.733206

mouseexperimental assay

𝕏 PostBluesky

ImmunologyNature ImmunologyPeer-reviewedJun 12, 2026

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models

Neha Agrawal, Louis S. Ates, Stefan A. Schille…·Uğur Şahin

This paper describes two mRNA vaccines for tuberculosis that are immunogenic, well-tolerated, and effective in rodent models, entering clinical trials.

9 citationstop 1%

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 8, 2026

Multi-dimensional optimization of a lysin towards a ribolysin against life-threatening S. aureus infections: Fc-LysM-CHAP and its strong synergy with standard of care antibiotics

Adriana Badarau, Benedikt Bauer, Zehra Visram…·Lorenzo Corsini

This paper develops an Fc-fused lysin, Fc-LysM-CHAP, optimized for improved pharmacokinetics and synergy with antibiotics against S. aureus infections.

1 citation

mousedeep learning

𝕏 PostBluesky

BiochemistryJournal of Biological ChemistryPeer-reviewedJul 30, 2025

Molecular characterization of the archaic HLA-B*73:01 allele reveals presentation of a unique peptidome and skewed engagement by KIR2DL2

Philipp Ross, Hugo G. Hilton, Jane E. Lodwick…·Erin J. Adams

The paper characterizes HLA-B*73:01, revealing its unique peptide binding motif, restricted peptidome, and distinct interaction with KIR2DL2, suggesting evolutionary advantages in pathogen resistance.

1 citation

humanproteomics

𝕏 PostBluesky